Published in Br J Clin Pharmacol on October 01, 1976
Investigation of diurnal changes in the disposition of theophylline. Br J Clin Pharmacol (1983) 1.29
Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease. Br J Clin Pharmacol (1984) 1.15
Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation. Br J Clin Pharmacol (1982) 0.94
Patient compliance with oral theophylline therapy. Br J Clin Pharmacol (1984) 0.90
Prediction of optimum oral theophylline dose in patients with obstructive airways disease. Br J Clin Pharmacol (1983) 0.90
Prediction of maintenance oral theophylline dosage using single oral doses in patients with obstructive airways disease. Br J Clin Pharmacol (1983) 0.75
Rational intravenous doses of theophylline. N Engl J Med (1973) 7.44
Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther (1972) 4.57
Study of theophylline plasma levels after oral administration of new theophylline compounds. Br Med J (1957) 2.71
An ultraviolet spectrophotometric method for the determination of theophylline and theobromine in blood and tissues. J Pharmacol Exp Ther (1949) 2.53
Specific gas chromatographic determination of xanthines and barbiturates by flash-heater N-butylation. J Chromatogr (1973) 1.10
Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther (1976) 3.16
The clinical pharmacology of mexiletine. Br J Clin Pharmacol (1978) 2.56
Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate. Clin Pharmacol Ther (1974) 1.81
Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol (1976) 1.71
Mexiletine (Kö 1173) in the management of ventricular dysrhythmias. Lancet (1973) 1.68
Clinical pharmacokinetics of oral anticoagulants. Clin Pharmacokinet (1979) 1.66
Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol. Eur J Clin Pharmacol (1980) 1.57
Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol. Br J Clin Pharmacol (1980) 1.55
Plasma digoxin concentrations in patients on admission to hospital. Br Heart J (1974) 1.46
Pharmacokinetics of enalapril in normal subjects and patients with renal impairment. Br J Clin Pharmacol (1986) 1.38
Spectrophotofluorometric and gas-liquid chromatographic methods for the estimation of mexiletine (Kö 1173) in plasma and urine. J Pharm Pharmacol (1973) 1.36
Duration of action of beta-blocking drugs. Br Med J (1973) 1.33
Measurement of plasma mexiletine concentrations. Postgrad Med J (1977) 1.28
Theophylline kinetics in relation to age: the importance of smoking. Br J Clin Pharmacol (1980) 1.23
Correlation of reduction of exercise heart rate with blood levels of atenolol after oral and intravenous administration. Postgrad Med J (1977) 1.13
A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Ann Rheum Dis (2007) 1.12
The development of mexiletine in the management of ventricular dysrhythmias. Postgrad Med J (1977) 1.09
Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasis. Trans R Soc Trop Med Hyg (1991) 1.08
The effects of captopril on the acute vascular responses to frusemide in man. Clin Sci (Lond) (1983) 1.08
Sotalol as a hypotensive agent in pregnancy. Br J Obstet Gynaecol (1980) 1.07
Do patients take digoxin? Br Heart J (1978) 1.06
Ecological constraints on mental health services. Am Psychol (1966) 1.00
Observation on the efficacy and pharmacokinetics of betaxolol (SL 75212), a cardioselective beta-adrenoceptor blocking drug. Br J Clin Pharmacol (1981) 1.00
Survey of medication documentation at hospital discharge: implications for patient safety and continuity of care. Ir J Med Sci (2008) 0.99
Beta-adrenoceptor adaptation to acute exercise. J Physiol (1983) 0.98
Clinical and pharmacokinetic properties of a transdermal nicotine patch. Clin Pharmacol Ther (1990) 0.98
Recombinant human interferon alpha increases oestrogen receptor expression in human breast cancer cells (ZR-75-1) and sensitizes them to the anti-proliferative effects of tamoxifen. Br J Cancer (1987) 0.98
The excretion of enalapril and enalaprilat in human breast milk. Eur J Clin Pharmacol (1990) 0.97
Mexiletine in normal volunteers. Br J Clin Pharmacol (1978) 0.97
Pharmacokinetics of low-dose methotrexate in children receiving maintenance therapy for acute lymphoblastic leukaemia. Cancer Chemother Pharmacol (1982) 0.94
Effects of thyroid dysfunction on propranolol kinetics. Clin Pharmacol Ther (1980) 0.92
The dose-response characteristics of the acute non-diuretic peripheral vascular effects of frusemide in normal subjects. Br J Clin Pharmacol (1984) 0.92
Qualities for the community psychologist. Am Psychol (1971) 0.92
The effects of propranolol and digoxin on the acute vascular responses to frusemide in normal man. Br J Clin Pharmacol (1985) 0.91
Lymphocyte cyclic AMP production in the elderly: the effects of prostaglandin E1. Br J Clin Pharmacol (1981) 0.90
Radioreceptor assay for labetalol. Br J Clin Pharmacol (1981) 0.87
Cardiac sensitivity to isoprenaline, lymphocyte beta-adrenoceptors and age. Clin Sci (Lond) (1984) 0.87
Differential blockade of alpha-adrenoceptors by indoramin. Br J Clin Pharmacol (1984) 0.86
Relationship of beta-adrenoreceptor density to fitness in athletes. Nature (1982) 0.86
Patient-controlled analgesia using a miniature electrochemically driven infusion pump. Br J Anaesth (1994) 0.86
Human lymphocyte beta-adrenoceptor density in relation to age and hypertension. J Cardiovasc Pharmacol (1982) 0.86
Plasma protein binding of propranolol and isoprenaline in hyperthyroidism and hypothyroidism. Br J Clin Pharmacol (1978) 0.85
Pharmacokinetics of a microcrystalline theophylline preparation in patients with chronic obstructive airways disease. Eur J Clin Pharmacol (1978) 0.83
Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs. Br J Clin Pharmacol (1977) 0.82
Adrenergic receptors in depression. Effects of electroconvulsive therapy. Br J Psychiatry (1985) 0.82
Pharmacokinetics of digoxin in the elderly [proceedings]. Br J Clin Pharmacol (1978) 0.82
Metabolic and cardiovascular effects of isoprenaline and salbutamol in the dog. Br J Pharmacol (1975) 0.82
Pharmacokinetics of digoxin alone and in the presence of indomethacin therapy. Br J Clin Pharmacol (1984) 0.81
Effect of hydrochlorothiazide on the pharmacokinetics of enalapril in hypertensive patients with varying renal function. J Cardiovasc Pharmacol (1996) 0.81
Sotalol in the management of hypertension complicating pregnancy [proceedings]. Br J Clin Pharmacol (1979) 0.80
Lisinopril population pharmacokinetics in elderly and renal disease patients with hypertension. Br J Clin Pharmacol (1989) 0.80
Adrenoceptors mediating metabolic responses in the greyhound. Br J Pharmacol (1971) 0.80
Effects of ranitidine on the disposition of metoprolol. Br J Clin Pharmacol (1985) 0.80
Digoxin "receptors" in neonates: an explanation of less sensitivity to digoxin than in adults. Clin Pharmacol Ther (1980) 0.79
The pharmacokinetics of paroxetine in renal impairment. Acta Psychiatr Scand Suppl (1989) 0.79
The effect of chronic captopril therapy on adrenergic receptors, plasma noradrenaline and the vascular responses to infused noradrenaline. Eur J Clin Pharmacol (1987) 0.79
Erythrocyte cation transport and age: effects of digoxin and furosemide. Clin Pharmacol Ther (1983) 0.79
Long term oral antiarrhythmic therapy with mexiletine. Postgrad Med J (1977) 0.79
The effect of age and smoking on theophylline kinetics [proceedings]. Br J Clin Pharmacol (1979) 0.79
Naturalistic observations and theory confirmation: an example. Hum Dev (1967) 0.79
Antidotes for arrogance: training for community psychology. Am Psychol (1970) 0.79
The clinical pharmacology of tolmesoxide. A new vasodilator antihypertensive agent. Eur J Clin Pharmacol (1982) 0.79
Comparison of the effects of lignocaine and mexiletine on experimental ventricular arrhythmias. Postgrad Med J (1977) 0.78
Bioavailability of labetalol increases with age. Br J Clin Pharmacol (1982) 0.78
A comparison of plasma levels of theophyllinates after oral administration. Br J Clin Pharmacol (1976) 0.78
Clinical pharmacology of tolmesoxide in refractory heart failure. Eur J Clin Pharmacol (1981) 0.78
Personality typing and anxiety for two groups of registered nurses. Aust J Adv Nurs (1985) 0.77
Adrenoceptor status and cardiovascular function in ageing. J Hypertens Suppl (1988) 0.77
Stress, coping behaviors, and recommendations for intensive care and medical surgical ward registered nurses. Res Nurs Health (1985) 0.77
Antihypertensive and renal effects of lisinopril in older patients with hypertension. Am J Med (1988) 0.77
Actions of R- and S-verapamil and nifedipine on rat vascular and intestinal smooth muscle. Auton Autacoid Pharmacol (2004) 0.76
Plasma and tissue digoxin concentrations in patients undergoing cardiopulmonary bypass. Br Heart J (1975) 0.76
Pharmacokinetics and haemodynamic effects of tocainide in patients with acute myocardial infarction complicated by left ventricular failure. Br J Clin Pharmacol (1985) 0.75
The effect of digoxin on 86rubidium uptake by erythrocytes from mothers and babies. Br J Clin Pharmacol (1983) 0.75
Diminished activity of glyceryl trinitrate. Br Med J (Clin Res Ed) (1982) 0.75
Sodium fluoride activation of human lymphocyte adenylate cyclase is reduced in old age. Br J Clin Pharmacol (1982) 0.75
Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers. Eur J Clin Pharmacol (1989) 0.75
Evidence for a circulating sodium transport inhibitor in essential hypertension. Br Med J (Clin Res Ed) (1981) 0.75
Observations on intravenous administration of lignocaine in patients with myocardial infarction. Br Heart J (1978) 0.75
Pharmacodynamics and pharmacokinetics of digoxin in the presence of lithium. Br J Clin Pharmacol (1984) 0.75
Effect of indoramin, labetalol and alinidine on sympathetic function in normal man. Br J Clin Pharmacol (1984) 0.75
Role of neural influences in the release of gastrin, glucagon, and secretin during hypoglycaemia in man. Gut (1978) 0.75
New developments in antihypertensive drugs. Trends Cardiovasc Med (2011) 0.75
Vasodilator therapy for acute heart failure: haemodynamic comparison of hydralazine/isosorbide, alpha-adrenoceptor blockade, and angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol (1992) 0.75
Liquid chromatographic determination of paracetamol and dextropropoxyphene in plasma. J Chromatogr (1987) 0.75
The kinetics of propranolol in hypothyroidism [proceedings]. Br J Clin Pharmacol (1980) 0.75
Lack of effect of diazepam on the ST segment of the electrocardiogram during maximal exercise stress testing in normal subjects. J Cardiovasc Pharmacol (1980) 0.75
Propranolol kinetics in hyperthyroidism [proceedings]. Br J Clin Pharmacol (1979) 0.75
The need to work together to succeed in breaking the nursing mould. Aust Nurses J (1984) 0.75
Staff stress in critical care units. Aust Health Rev (1988) 0.75
Community psychology: some priorities for the immediate future. J Community Psychol (1975) 0.75
Pharmacokinetics of amlodipine in renal impairment. J Cardiovasc Pharmacol (1988) 0.75
The effect of chronic captopril therapy on platelet angiotensin II receptor density and vascular responsiveness to angiotensin II infusion. Eur J Clin Pharmacol (1987) 0.75
Estimation of concentrations of diltiazem in plasma using normal-phase column liquid chromatography with ultraviolet detection. J Chromatogr (1986) 0.75
A study of the potential pharmacokinetic interaction of lisinopril and digoxin in normal volunteers. Xenobiotica (1988) 0.75
Biliary excretion and enterohepatic recirculation of practolol in man. Ir J Med Sci (1976) 0.75
Pharmacokinetics of lignocaine in the elderly [proceedings]. Br J Clin Pharmacol (1980) 0.75
The clinical pharmacology of vasodilator antihypertensive drugs. Arch Int Pharmacodyn Ther (1980) 0.75
The mental health agent in the urban community. Rep Group Adv Psychiatry (1964) 0.75
Social support and efficacy in advocacy roles. A case study of two women's organizations. Issues Ment Health Nurs (1983) 0.75